Published on
June 4, 2025
- 08:52 GMT
MarkHerz Signs MOU with TUM Hospital for Joint Development of Cardiovascular and Diabetes-Targeted AAV Gene Therapies
MarkHerz Signs MOU with TUM Hospital for Joint Development of Cardiovascular and Diabetes-Targeted AAV Gene Therapies MUNICH, BAYERN, GERMANY, June 4, 2025 /EINPresswire.com/ -- Paving the Way for European Clinical Entry and Global Technology Transfer …
Distribution channels:
Business & Economy, Companies
...
